Medicare payment in January helps MD Anderson reduce its operating losses

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

MD Anderson Cancer Center reduced its year-to-date operating loss to $77.3 million in January, the fifth month of the fiscal year.

In January, the cumulative operating loss was $169.4 million. The loss shrunk because in January MD Anderson booked about $63.4 million in a settlement from Medicare, which allowed the cancer center to claim a portion of its expenses for implementing the Epic system.

Due to increased clinical activity by about 10 percent from December to January, operating revenues were around $28.7 million. This the first monthly positive margin since Epic’s rollout in March 2016.

In an interview with The Cancer Letter, MD Anderson Chief Operating Officer Steve Hahn said the installation, which he described as the largest in the history of Epic, changed over the cancer center’s inpatient, outpatient and billing systems at the same time.

Hahn, deputy to the president, said the installation of Epic exposed and exacerbated inefficiencies in the cancer center’s operations.

The text of the interview with Hahn appears here.

The cancer center’s financials appear below:

MD Anderson Cancer Center Monthly Financials,
September 2016 to January 2017

MDACC-1

Paul Goldberg
Editor & Publisher
Table of Contents

YOU MAY BE INTERESTED IN

The Trump administration did exactly what it said it would do to disorient anyone involved in making policy or touched by it. The president and his crew have “flooded the zone”—the term and the image are theirs, as is the strategy of dropping a flurry of executive orders and memoranda that shake the foundations of the American system of government, raising questions of legality and constitutionality, and, above all, making it a challenge for anyone to see the entire picture and think strategically.
In two raucous back-to-back hearings on Jan. 29 and Jan. 30, anti-vaccine crusader Robert F. Kennedy Jr. was grilled by members of the United States Senate Finance Committee and the Health, Education, Labor, and Pensions Committee as the Trump administration seeks his confirmation as secretary of the Department of Health and Human Services. 
Over the past century, groundbreaking cancer research in the U.S. has led to life-saving medical advances that benefit patients worldwide. Scientists often devote their lives to making discoveries, putting their scientific endeavors ahead of status, income, or lifestyle. Investigators work tirelessly, often seven days a week, to solve complex medical problems. These efforts often lead to game-changing outcomes that help us understand difficult medical challenges, advance technologies and develop new therapies. 
Paul Goldberg
Editor & Publisher

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login